Inventiva (IVA) vs. CRSP and MDGL: Can Lanifibranor’s Phase 3 Trial Unlock 62% Upside?
Is IVA a good stock to buy? We came across a bullish thesis on Inventiva S.A. on BioEquity Watch’s Substack.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Hurley Capital Charles Goldblum | 10,000 | $36,900 | 0.02% | |
| 2. | Leucadia National Ian Cumming And Joseph Steinberg | 0 | $0 | 0% | |
| 3. | Syquant Capital Olivier Leymarie And Henri Jeantet | 0 | $0 | 0% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,754,577 | $17,544,390 | 0% | |
| 2. | 3,633,181 | $13,406,438 | 7.63% | |
| 3. | 3,145,711 | $11,607,674 | 0.02% | |
| 4. | 1,850,222 | $6,827,319 | 0% | |
| 5. | 1,221,225 | $4,506,320 | 0.72% |